Testing for minimal residual disease in adults with acute lymphoblastic leukemia in Europe: a clinician survey

about

Testing for minimal residual disease in adults with acute lymphoblastic leukemia in Europe: a clinician survey

Item

http://www.wikidata.org/entity/Q59127308

description

im November 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в листопаді 2018

@uk

name

Testing for minimal residual d ...... in Europe: a clinician survey

@en

Testing for minimal residual d ...... in Europe: a clinician survey

@nl

type

Item

label

Testing for minimal residual d ...... in Europe: a clinician survey

@en

Testing for minimal residual d ...... in Europe: a clinician survey

@nl

prefLabel

Testing for minimal residual d ...... in Europe: a clinician survey

@en

Testing for minimal residual d ...... in Europe: a clinician survey

@nl

P1476

Testing for minimal residual d ...... in Europe: a clinician survey

@en

P2093

Anja K Pownell

http://www.w3.org/2001/XMLSchema#string

Arnaud Pigneux

http://www.w3.org/2001/XMLSchema#string

Heather Wieffer

http://www.w3.org/2001/XMLSchema#string

Jan McKendrick

http://www.w3.org/2001/XMLSchema#string

Monika Brüggemann

http://www.w3.org/2001/XMLSchema#string

Pau Montesinos

http://www.w3.org/2001/XMLSchema#string

Xinke Zhang

http://www.w3.org/2001/XMLSchema#string

Ze Cong

http://www.w3.org/2001/XMLSchema#string

P2860

Minimal residual disease assessed by multi-parameter flow cytometry is highly prognostic in adult patients with acute lymphoblastic leukaemia

Modern therapy of acute lymphoblastic leukemia.

Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL).

Impact of minimal residual disease, detected by flow cytometry, on outcome of myeloablative hematopoietic cell transplantation for acute lymphoblastic leukemia.

Association of Minimal Residual Disease With Clinical Outcome in Pediatric and Adult Acute Lymphoblastic Leukemia: A Meta-analysis.

Acute lymphoblastic leukemia: a comprehensive review and 2017 update

Minimal residual disease is a significant predictor of treatment failure in non T-lineage adult acute lymphoblastic leukaemia: final results of the international trial UKALL XII/ECOG2993.

Acute lymphoblastic leukemia: an assessment of international incidence, survival, and disease burden.

Improving the quality of Web surveys: the Checklist for Reporting Results of Internet E-Surveys (CHERRIES).

Different molecular levels of post-induction minimal residual disease may predict hematopoietic stem cell transplantation outcome in adult Philadelphia-negative acute lymphoblastic leukemia.

P2888

s12885-018-5002-5

P304

1100

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12885-018-5002-5

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-11-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1109821992

http://www.w3.org/2001/XMLSchema#string

P698

30419861

http://www.w3.org/2001/XMLSchema#string

P921

leukemia

P932

6233570

http://www.w3.org/2001/XMLSchema#string